Kontrol Technologies Corp. reports developments tied to smart buildings, building services, and energy efficiency solutions. The Canadian public company provides integrated HVAC, building automation, and energy management services for commercial, industrial, multi-residential, and residential properties, with recent activity centered on Ontario and broader Canadian building markets.
Recurring company news includes financial results filed in Canada, project awards with building owners, customer-base expansion, acquisition criteria for HVAC and related service businesses, and capital actions such as its completed normal course issuer bid. Governance updates include annual meeting voting results, auditor appointment, director elections, and share compensation plan matters. Kontrol has also described its operating focus after the completed sale of the operational net assets of CEM Specialties Inc.
Kontrol Technologies Corp. (CSE: KNR) (OTCQB: KNRLF) has announced plans for a normal course issuer bid (NCIB) allowing the purchase of up to 2,061,236 common shares over the next 12 months, starting March 25, 2021. This represents about 5% of the total shares outstanding as of March 24, 2021. The board believes the current market price does not reflect the company's growth opportunities, aiming to enhance shareholder value. Previous NCIB saw the purchase of 30,500 shares at an average price of $0.58 CDN. The purchases will be executed by PI Financial Corporation.
Kontrol Technologies Corp. (CSE: KNR) (OTCQB: KNRLF) has partnered with Canadian Sport Institute Pacific to implement its Kontrol BioCloud viral detection technology at the Whistler Athletes Centre. This real-time analyzer detects airborne pathogens like COVID-19, enhancing safety for athletes training for the Tokyo Olympics. Paul Ghezzi, CEO, emphasizes the technology's role in restoring normalcy in athletics. The partnership supports athletes under strict COVID-19 protocols, allowing high-performance training while minimizing health risks.
Kontrol Technologies Corp. (CSE: KNR) (OTCQB: KNRLF) announced a collaboration with Foyer Richelieu Welland, a long-term care facility in Ontario, to implement its Kontrol BioCloud technology. This real-time viral detection system aims to monitor airborne pathogens, including COVID-19. CEO Paul Ghezzi emphasized the importance of BioCloud in creating safer environments, especially in light of ongoing COVID-19 protocols. The partnership focuses on ensuring a secure space for residents through effective real-time monitoring.
Kontrol Technologies Corp. (CSE:KNR, OTCQB:KNRLF) is set to showcase real-time demonstrations of its BioCloud units across various customer applications, pending approvals. The company's CEO, Paul Ghezzi, emphasized the importance of sharing operational data when permissible. Additionally, Kontrol has reduced the number of circuit boards in BioCloud from 11 to 5, enhancing production efficiency and potentially lowering costs. With 11 distributors and ongoing negotiations for USA and Middle East agreements, Kontrol is adapting its distribution model to optimize market presence.
Kontrol Technologies Corp. (CSE:KNR, OTCQB:KNRLF) has established a scientific advisory board to accelerate the development of its BioCloud technology for real-time viral detection. CEO Paul Ghezzi emphasizes the necessity of advanced detection technology alongside vaccines for economic recovery. The advisory board comprises prominent experts, including Dr. Caroline Duchaine and Dr. David Heinrichs, who will guide the innovation of BioCloud applications. This initiative positions Kontrol as a leader in the emerging field of viral detection technology.
Kontrol Technologies Corp. has received approval from the Canadian Securities Exchange to change its name to Kontrol Technologies Corp., effective February 12, 2021. The company's share ticker symbols will remain unchanged: CSE: KNR, OTCQB: KNRLF, and FSE: 1K8. No action is required from shareholders due to this name change, and existing share certificates will remain valid. The company specializes in smart buildings through IoT, Cloud, and SaaS technologies aimed at improving energy management and air quality.
Kontrol Technologies Corp. (CSE:KNR / OTCQB:KNRLF) has engaged Digital Offering, LLC as its financial advisor to explore U.S. Capital Markets and aim for a potential NASDAQ listing. CEO Paul Ghezzi emphasized the importance of increasing visibility in the U.S. market. Digital Offering will receive an initial fee of US $25,000 and a success fee of US $175,000 upon a successful listing, along with 400,000 consultant warrants. Kontrol is focused on enhancing its institutional shareholder base and long-term value.
Kontrol Technologies Corp. has announced a $2 million investment from the Ontario government through the Ontario Together Fund to accelerate the production of its innovative COVID-19 detection technology, BioCloud. This funding will enable CEM Specialties Inc., a subsidiary of Kontrol, to increase production capacity to 20,000 units per month, creating up to 250 direct and 750 indirect jobs. BioCloud will provide real-time monitoring of SARS-CoV-2 in the air and is designed for various public spaces. The investment is contingent on achieving specific production milestones by March 30, 2021.
Kontrol Energy Corp. (CSE:KNR, OTCQB:KNRLF) is set to ship its BioCloud unit to the UAE for a three-week field demonstration starting December 13, 2020. CEO Paul Ghezzi noted significant regional interest in the viral detection technology. The BioCloud unit will now support modbus and bacnet protocols for integration with HVAC systems, enhancing its applicability in smart building environments. This upgrade applies to all future units as well. BioCloud operates as a real-time air quality analyzer, although it does not claim to eliminate or cure COVID-19.
Kontrol Energy Corp. (CSE:KNR, OTCQB:KNRLF) has signed an exclusive Distribution Agreement with United Safety and Survivability Corporation to distribute its BioCloud technology in North America, Australia, and New Zealand. The agreement spans a 12-month exclusivity period, with a mutual six-month renewal option, covering various transportation sectors including buses and ambulances. The arrangement targets production of 5,000 units annually. However, pricing details remain undisclosed for competitive reasons. The BioCloud technology aims to enhance air quality and safety in public spaces impacted by COVID-19.